EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Icariin Enhances the Enzymatic Activity of N‐acetylgalactosaminidase to Augment Akkermansia Abundance in Gut Microbiota for Improved PD‐1 Blockade Efficacy in Tumor Suppression

Shuangying Qiao, Liu Yang, Haibang Hao, Qiuxia Ding, Feng Ding, Zheng Chen, Jinfang Zhang, Yun He, Meng Li, Jun Xu, Chao Wang, Aiping Lu und 1 weitere

Advanced Science · 2026-07 · 13 (40)

DOI: 10.1002/advs.202519942 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 22.04.2026. Verfasst von Shuangying Qiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Shum Yiu Foon Sum Bik Chuen Memorial Centre for Cancer and Inflammation Research (CCIR), School of Chinese Medicine, Hong Kong Baptist University, Ho…. Hauptthemen laut MEDLINE: Flavonoids, Gastrointestinal Microbiome, Akkermansia, Programmed Cell Death 1 Receptor. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hong Kong General Research Fund, Hong Kong RGC Theme-based Research Scheme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Akkermansia (Akk) is a commensal bacterium in gut microbiota known to enhance anti‐tumor immunity and improve responses to immunotherapy. However, the clinical translation of Akk‐based therapies still faces critical challenges, including intestinal colonization difficulties, inter‐patient variability, and safety risks. Here, we identified the flavonoid icariin as a novel prebiotic candidate that could specifically enrich intestinal Akk abundance under various conditions both in vivo and in vitro. Oral administration of icariin selectively increased intestinal Akk abundance in tumor‐bearing and non‐tumor mice, regardless of their immunocompetent or immunodeficient status. Moreover, in vitro assays confirmed that icariin promoted Akk growth in a mucin‐dependent manner. Transcriptomic and metabolomic analyses revealed that icariin enhanced mucin‐associated metabolic pathways to support Akk growth. Mechanistically, we found that icariin increased the enzymatic activity of N‐acetylgalactosaminidase Amuc_0920 by stabilizing key residues at the binding sites for the substrate GalNAc, which enhanced mucin catabolism and promoted Akk growth. Functionally, we further found that this Akk enrichment enhanced intratumoral CD8+ T cell functions by single‐cell RNA sequencing. Consequently, icariin‐induced Akk enrichment significantly enhanced the efficacy of anti‐PD‐1 immunotherapy in tumor mouse models. These findings establish icariin as a promising Akk‐targeting prebiotic that selectively enriches Akk to improve cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavonoidsGastrointestinal MicrobiomeAkkermansiaProgrammed Cell Death 1 ReceptorImmune Checkpoint InhibitorsNeoplasmsAnimalsMiceHumansMice, Inbred C57BL

Stichwörter der Autor:innen

Akkermansiacancergut microbiotaicariinimmunotherapytumor immune microenvironment

Substanzen

FlavonoidsicariinProgrammed Cell Death 1 ReceptorImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Shum Yiu Foon Sum Bik Chuen Memorial Centre for Cancer and Inflammation Research (CCIR), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, P. R. China.
  • Institute of Integrated Bioinfomedicine and Translational Science (IBTS), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, P. R. China.
  • Institute of Precision Medicine and Innovative Drug Discovery (PMID), School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, P. R. China.
  • Department of Laboratory Medicine, The Third Affiliated Hospital of Shenzhen University, Shenzhen, P. R. China.
  • Department of Urology, The Third Affiliated Hospital of Shenzhen University, Shenzhen, P. R. China.
  • Institute of Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, Guangdong, P. R. China.

ORCID-Profile: Fangfei Li

Förderung

  • Hong Kong General Research Fund
  • Hong Kong RGC Theme-based Research Scheme

Zitieren

APA

Qiao, S., Yang, L., Hao, H., Ding, Q., Ding, F., Chen, Z., Zhang, J., He, Y., Li, M., Xu, J., Wang, C., Lu, A., & Li, F. (2026). Icariin Enhances the Enzymatic Activity of N‐acetylgalactosaminidase to Augment Akkermansia Abundance in Gut Microbiota for Improved PD‐1 Blockade Efficacy in Tumor Suppression. Advanced Science, 13(40). https://doi.org/10.1002/advs.202519942

Vancouver

Qiao S, Yang L, Hao H, Ding Q, Ding F, Chen Z, et al. Icariin Enhances the Enzymatic Activity of N‐acetylgalactosaminidase to Augment Akkermansia Abundance in Gut Microbiota for Improved PD‐1 Blockade Efficacy in Tumor Suppression. Advanced Science. 2026;13(40). doi:10.1002/advs.202519942

BibTeX
@article{Qiao2026,
  author = {Qiao, Shuangying and Yang, Liu and Hao, Haibang and Ding, Qiuxia and Ding, Feng and Chen, Zheng and Zhang, Jinfang and He, Yun and Li, Meng and Xu, Jun and Wang, Chao and Lu, Aiping and Li, Fangfei},
  title = {Icariin Enhances the Enzymatic Activity of N‐acetylgalactosaminidase to Augment Akkermansia Abundance in Gut Microbiota for Improved PD‐1 Blockade Efficacy in Tumor Suppression},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {40},
  doi = {10.1002/advs.202519942}
}
Kostenlos starten →